Synermed is the world's leading developer of quality analytical methods in clinical chemistry. The company's design focus is two areas of traditional weakness of conventional chemistries, namely the elimination of common interferences and the stabilization of enzymes in liquid reagents.As has been highlighted by the work of Glick and others, almost all conventional procedures for routinely automated chemistries exhibit substantial residual interferences in samples compromised by hemolysis, icterus or turbidity. All of the consequences of these interferences are unwelcome, from specimen rejection, to special handling, repeat testing and misleading clinical information. Ultimately, in a field which is constantly pressured to contain cost, laboratories pay a disproportionate surcharge to process a minority of specimens, on which the results are still flawed.
